Ovarian carcinoma contributes significantly to cancer-associated mortality in women, highlighting the urgent need for effective early detection strategies. Despite CA-125 (Cancer antigen 125) being widely used, it lacks reliable biomarkers for early diagnosis, requiring the exploration of alternative biomarkers such as miRNA, lncRNA and DNA methylation. As well, algorithms such as ROMA (Risk of Ovarian Malignancy Algorithm), RMI (Risk of Malignancy Index) and OVA1 (Ovarian Cancer Risk Assessment Algorithm 1) aim to enhance early detection accuracy. With an emphasis on epigenetic changes, this review synthesizes recent advances in molecular biomarkers and algorithms for early ovarian cancer diagnosis, providing insights into improving detection accuracy and managing disease.